July 8, 2020 / 11:44 AM / a month ago

BRIEF-Kitov Pharma Receives Notice Of Intention To Grant A European Patent Covering Cm24, Its Anti-Ceacam1 Antibody

July 8 (Reuters) - Kitov Pharma Ltd:

* KITOV PHARMA RECEIVES NOTICE OF INTENTION TO GRANT A EUROPEAN PATENT COVERING CM24, ITS ANTI-CEACAM1 ANTIBODY

* KITOV PHARMA LTD - CM24 TRIAL TO BE CONDUCTED UNDER CLINICAL COLLABORATION AGREEMENT WITH BRISTOL-MYERS SQUIBB CO, IS EXPECTED TO BEGIN IN H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below